Tumor heterogeneity affects the precision of microarray analysis

Diagnostic Molecular Pathology

Volumn 14, Issue 2, 2005, Pages 65-71

  O'Sullivan, Maureen ^a   Budhraja, Vikram ^b   Sadovsky, Yoel ^c   Pfeifer, John D ^c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical microarray analysis; Ewing sarcoma; Gene expression

Indexed keywords

ACCURACY; ARTICLE; CELL HETEROGENEITY; CELL LINE; DNA MICROARRAY; EWING SARCOMA; GENE EXPRESSION; GENE PROBE; HUMAN; HUMAN CELL; NEUROECTODERM TUMOR; PRIORITY JOURNAL; PROGNOSIS; RNA EXTRACTION; TROPHOBLAST;

BONE NEOPLASMS; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; HUMANS; NEUROECTODERMAL TUMORS, PRIMITIVE, PERIPHERAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPRODUCIBILITY OF RESULTS; SARCOMA, EWING'S;

EID: 19544381883     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000158988.46025.f6     Document Type: Article

References (37)

1. Dhanasekaran S, Barrette T, Ghosh D, et al. Delineation of prognostic biomarkers in prostate cancer. Nature, 2001;412:822-826.
2. Ramaswamy S, Golub T. DNA microarrays in clinical oncology. J Clin Oncol. 2002;20:1932-1941.
3. Alizadeh A, Eisen M, Davis R, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403: 503-511.
4. Hedenfalk I, Duggan D, Chen Y, et al. Gene-expression profiles in hereditary breast cancer. N Engl J Med. 2001;344:539-548.
5. van't Veer L, Dai H, van de Vijver M, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature, 2002;415:530-536.
6. Gordon G, Jensen R, Hsiao L, et al. Using gene expression ratios to predict outcome among patients with mesothelioma. J Natl Cancer Inst. 2003;95:598-605.
7. DeRisi J, Penland L, Brown P, et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet. 1996; 14:457-460.
8. Bubendorf L, Kolmer M, Kononen J, et al. Hormone therapy failure in human prostate cancer: Analysis by complementary DNA and tissue microarrays. J Natl Cancer Inst. 1999;91:1758-1764.
9. Takahashi M, Rhodes D, Purge K, et al. Gene expression profiling of clear cell renal cell carcinoma: Gene identification and prognostic classification. Proc Natl Acad Sci U S A. 2001;98:9754-9759.
10. Sgroi D, Teng S, Robinson G, et al. in vivo gene expression profile analysis of human breast cancer progression. Cancer Res. 1999;59:5656-5661.
11. Tusher V. Tibshirani R, Chu G, Significance analysis of microarrays applied to the ionizing radiation response, Proc Natl Acad Sci U S A. 2001;98:5116-5121.
12. Butte A, Ve J, Haring H, et al. Determining significant fold differences in gene expression analysis. Pac Symp Biocomput 2001, 6-17.
13. Mills J, Gordon J, A new approach for filtering noise from high-density oligonucleotide microarray datasets, Nucleic Acids Res. 2001;29:e72.
14. Ideker T, Thorsson V, Siegel AF, et al. Testing for differentially- expressed genes by maximum-likelihood analysis of microarray data. J Comput Biol. 2000;7:805-817.
15. Mariani T, Budhraja V, Mecham B, et al. A variable fold change threshold determines significance for expression microarrays. FASEB J. 2002;10: 109. (Epub)
16. Yang Y, Dudoit S, Luu P, et al. Normalization for cDNA microarray data: A robust composite method addressing single and multiple slide systematic variation, Nucleic Acids Res. 2002;30:e15.
17. Goldenberg D, Ayesh S, Schneider T, et al. Analysis of differentially expressed genes in hepatocellular carcinoma using cDNA arrays. Mol Carcinog. 2002;33:113-124.
18. Cheung V, Conlin L, Weber T, et al. Natural variation in human gene expression assessed in lymphoblastoid cells, Nat Genet. 2003;33:422-425.
19. Wigle DA, Jurisica I, Radulovich N, et al. Molecular profiling of non-small cell lung cancer and correlation with disease-free survival, Cancer Res. 2002;62:3005-3008.
20. Budhraja V, Spitznagel E, Schaiff T, et al. Incorporation of gene specific variability improves expression analysis using high-density DNA micro-arrays, BMC Biol. 2003; 1:1-8.
21. Hamelin R, Zucman J, Melot T, et al. p53 Mutations in human tumors with chimeric EWS/FLI-l genes. Int J Cancer. 1994;57:336-340.
22. Tsien C, Libermann T, Gu X, et al. On reporting fold differences, Pac Symp Biocomput 2001, 496-507.
23. Baldi P, Long A. A Bayesian framework for the analysis of microarray expression data: Regularized t-test and statistical inferences of gene changes. Bioinformatics, 2001;17:509-519.
24. Yang Y, Dudoit S, Luu P, et al. Normalization for cDNA microarray data: A robust composite method addressing single and multiple slide systematic variation, Nucleic Acids Res, 2002;30:1-10.
25. Durbin B, Hardin J, Hawkins D, et al. Approximate variance-stabilizing transformations for gene-expression microarray data. Bioinformatics. 2002;18:S105-S110.
26. Rocke D, Durbin B. A model for measurement error for gene expression arrays. J Comput Biol. 2001;8:557-569.
27. Oliveira A, Fletcher J. CHIPing soft tissue tumors: Will the paradigms be changed? Adv Anat Pathol. 2003; 10:1-7.
28. Khan J, Wei J, Ringner M, et al. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks, Nat Med. 2001;7:673-679.
29. Zellweger T, Ninck C, Mirlacher M, et al. Tissue microarray analysis reveals prognostic significance of syndecan-expression in prostrate cancer, Prostate. 2003;55:20-29.
30. Moore K. The Developing Human: Clinically Oriented Embryology, 7th ed. Elsevier Science 2003.
31. Diaz-Cano S, Blanes A, Rubio J, et al. Molecular evolution and intratumor heterogeneity by topographic compartments in muscle-invasive transitional cell carcinoma of the urinary bladder. Lab Invest. 2000;80:279-289.
32. Nicholson J, Ross F, Ellison D. Comparison genomic hybridization and histological variation in primitive neuroectodermal tumours, Br J Cancer. 1999;80:1322-1331.
33. Tarkkanen M, Kiuru-Kuhlefelt S, Blomqvist C, et al. Clinical correlations of genetic changes by comparative genomic hybridization in Ewing sarcoma and related tumors, Cancer Genet Cytogenet. 1999;114;35-41.
34. Ramaswamy S, Ross K, Lander E, et al. A molecular signature of metastasis in primary solid tumors, Nat Genet. 2003;33:49-54.
35. Fidler I, Kriple M. Genomic analysis of primary tumors does not address the prevalence of metastatic cells in the population. Nat Genet. 2003; 34:23.
36. Sugiyama Y, Sugiyama K, Hirari Y, et al. Microdissection is essential for gene expression profiling of clinically resected cancer tissues. Am J Clin Pathol. 2002;117:109-116.
37. Bittner M, Meltzer P, Chen Y, et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling, Nature. 2000;406: 536-540.